Cite
HARVARD Citation
Smith, I. et al. (2020). Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial. Lancet oncology. 21 (11), pp. 1443-1454. [Online].